Alkeon Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.1M | Hold |
4,504,096
| – | – | 0.26% | 77 |
|
|
2025
Q4 | $36.8M | Hold |
4,504,096
| – | – | 0.16% | 96 |
|
|
2025
Q3 | $54M | Hold |
4,504,096
| – | – | 0.24% | 80 |
|
|
2025
Q2 | $45.7M | Buy |
4,504,096
+500,000
| +12% | +$3.36M | 0.22% | 80 |
|
|
2025
Q1 | $22.3M | Buy |
4,004,096
+100,000
| +3% | +$874K | 0.13% | 91 |
|
|
2024
Q4 | $31.5M | Hold |
3,904,096
| – | – | 0.18% | 79 |
|
|
2024
Q3 | $40M | Buy |
3,904,096
+100,000
| +3% | +$989K | 0.22% | 78 |
|
|
2024
Q2 | $26.9M | Buy |
3,804,096
+100,000
| +3% | +$895K | 0.14% | 89 |
|
|
2024
Q1 | $50.9M | Buy |
3,704,096
+100,000
| +3% | +$1.19M | 0.28% | 79 |
|
|
2023
Q4 | $33.2M | Buy |
3,604,096
+124,807
| +4% | +$902K | 0.22% | 81 |
|
|
2023
Q3 | $21M | Buy |
3,479,289
+500,000
| +17% | +$4.1M | 0.13% | 86 |
|
|
2023
Q2 | $23.1M | Buy |
2,979,289
+580,037
| +24% | +$3.29M | 0.14% | 94 |
|
|
2023
Q1 | $13.7M | Hold |
2,399,252
| – | – | 0.09% | 108 |
|
|
2022
Q4 | $14.1M | Buy |
2,399,252
+292,284
| +14% | +$987K | 0.11% | 112 |
|
|
2022
Q3 | $6.74M | Hold |
2,106,968
| – | – | 0.05% | 127 |
|
|
2022
Q2 | $9.44M | Buy |
2,106,968
+200,000
| +10% | +$798K | 0.06% | 125 |
|
|
2022
Q1 | $10.2M | Buy |
1,906,968
+480,000
| +34% | +$4.32M | 0.05% | 132 |
|
|
2021
Q4 | $21M | Buy |
1,426,968
+429,979
| +43% | +$6.7M | 0.07% | 123 |
|
|
2021
Q3 | $20.8M | Hold |
996,989
| – | – | 0.07% | 133 |
|
|
2021
Q2 | $17.6M | Sell |
996,989
-1,072
| -0.1% | -$23.5K | 0.06% | 148 |
|
|
2021
Q1 | $24.5M | Buy |
998,061
+100,000
| +11% | +$3.16M | 0.09% | 132 |
|
|
2020
Q4 | $30.4M | Buy |
898,061
+595,000
| +196% | +$17.1M | 0.12% | 126 |
|
|
2020
Q3 | $7.58M | Buy |
+303,061
| New | +$7.21M | 0.04% | 132 |
|
Other funds holding ORIC
NI
EC
SOCM
P
VA
NMC
